2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( <u>Part 3</u> –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays)Bart Corsaro, Meina Liang, Arno Kromminga et al.|Bioanalysis|2021Cited by 60
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody AssaysBoris Gorovits, Bonnie Wu, Mark Odell et al.|The AAPS Journal|2021Cited by 52
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene TherapyBoris Gorovits, Bonnie Wu, Vibha Jawa et al.|The AAPS Journal|2023Cited by 41
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)LiNa Loo, Robert Kubiak, Kimberly Maxfield et al.|Bioanalysis|2022Cited by 35
Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirementsManuela Braun, Mark Milton, Wibke Lembke et al.|Molecular Therapy — Methods & Clinical Development|2024Cited by 25